BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:09 PM
 | 
Sep 26, 2012
 |  BC Extra  |  Company News

FDA accepts resubmitted Eliquis NDA

Bristol-Myers Squibb Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) said FDA accepted a resubmitted NDA for Eliquis apixaban to reduce the risk...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >